Core Insights - Bunge Global SA (BG) is set to report its second-quarter 2025 results on July 30, with expected sales of $11.4 billion, reflecting a 14.2% decline year-over-year [1] - The consensus estimate for earnings per share is $1.19, indicating a significant year-over-year drop of 31.2% [1] - Earnings estimates have remained unchanged over the past 30 days [1] Financial Performance Expectations - The Agribusiness segment is projected to generate revenues of $7.75 billion, down 19.7% from $9.66 billion in the prior year [6] - The adjusted EBIT for the Agribusiness segment is expected to be $202 million, a 32% decrease from the previous year [7] - The Refined and Specialty Oils segment is anticipated to report revenues of $3.18 billion, showing a slight growth of 1.8% year-over-year, but with a 28.2% drop in operating income [8] - The Milling segment's revenues are estimated at $419 million, reflecting a 4.5% increase from the year-ago period [9] Earnings Surprise History - Bunge's earnings have exceeded consensus estimates in two of the last four quarters, with an average surprise of 9.2% [2][3] Stock Performance - Bunge's stock has declined by 29.7% over the past year, compared to an 11.5% decline in the industry [11]

Thailand is making a last-ditch effort to avert a punitive 36% export levy with offers of greater market access for US farm and industrial goods https://t.co/eKwocWnWaM ...

Core Viewpoint - Philippe Laffont of Coatue Management has invested significantly in Philip Morris International, indicating the company's potential as a growth stock within the defensive tobacco industry [1][3][17] Investment Details - Laffont purchased over $220 million worth of Philip Morris stock in Q1, marking it as his fourth-largest purchase and second-largest new addition [3] - This investment is notable given Laffont's typical focus on technology stocks, which include major companies like Meta Platforms and Amazon [2] Growth Drivers - Philip Morris is experiencing growth through its smokeless products, particularly Zyn and Iqos, which are appealing alternatives to traditional tobacco [5][8] - Zyn's U.S. shipment volumes surged 53% to 202 million cans in Q1, prompting an increase in full-year shipment guidance to between 800 million and 840 million cans [7] - Iqos has also seen a nearly 12% increase in heated tobacco units (HTUs) to 37.1 billion units, with strong sales growth in Japan and Europe [9] Market Position - Philip Morris has successfully bought back Iqos' U.S. rights and is preparing for a broader rollout in the U.S. market, which could enhance growth without cannibalizing existing customers [10] - The company has managed to produce modest cigarette volume growth internationally, contrasting with the steep decline seen in the U.S. market [12][13] Financial Metrics - Zyn and Iqos have better unit economics compared to traditional cigarettes, with Zyn offering six times better product contribution levels and Iqos providing 2 to 2.5 times [11] - The stock is currently trading at a forward P/E ratio of under 23 and a PEG ratio of under 0.35, suggesting it is undervalued [15] Conclusion - Given its defensive nature, growth potential, and attractive valuation, Philip Morris is viewed as a favorable investment opportunity [14][17]